Cargando…
Research progress of extracellular vesicles as biomarkers in immunotherapy for non-small cell lung cancer
Lung cancer is one of the most severe forms of malignancy and a leading cause of cancer-related death worldwide, of which non-small cell lung cancer (NSCLC) is the most primary type observed in the clinic. NSCLC is mainly treated with surgery, radiotherapy, and chemotherapy. Additionally, targeted t...
Autores principales: | Ge, Yang, Ye, Ting, Fu, Siyun, Jiang, Xiaoying, Song, Hang, Liu, Bin, Wang, Guoquan, Wang, Jinghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162406/ https://www.ncbi.nlm.nih.gov/pubmed/37153619 http://dx.doi.org/10.3389/fimmu.2023.1114041 |
Ejemplares similares
-
Neutrophil extracellular traps in tumor progression and immunotherapy
por: Yan, Meina, et al.
Publicado: (2023) -
Extracellular Vesicles as Biomarkers in Cancer Immunotherapy
por: Mathew, Matthen, et al.
Publicado: (2020) -
Engineered Tumor-Derived Extracellular Vesicles: Potentials in Cancer Immunotherapy
por: Taghikhani, Adeleh, et al.
Publicado: (2020) -
Immunotherapy efficacy predictive tool for lung adenocarcinoma based on neural network
por: Li, Wei, et al.
Publicado: (2023) -
Small extracellular vesicles induce resistance to anti-GD2 immunotherapy unveiling tipifarnib as an adjunct to neuroblastoma immunotherapy
por: Liu, Xiaoming, et al.
Publicado: (2022)